In this study, we used U937 cells, which do not express NDRG2, to investigate whether NDRG2 affects cancer drug sensitivity, because the acute myeloid leukemia cell line, U937, is relatively resistant to As2O3 [23,24]. This evidence concerns the gene NDRG2 and cancer.